Le Lézard
Classified in: Business
Subject: INO

Pre-Market Technical Scan on Entertainment Equities -- AMC Networks, CBS Corp., Comcast, and Lions Gate


NEW YORK, April 19, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment community.  Today we are offering reports on AMCX, CBS, CMCSA, and LGF-A which can be accessed for free by signing up to www.wallstequities.com/registration. Today's pre-market research on WallStEquities.com is focused on the Entertainment industry, which is a constantly evolving group, with prospects in certain subsectors being much better than in others. Revenue trends in certain core segments, including broadcast television and radio, tend to vary with consumers' and advertisers' preferences towards new forms of media. Lined up for review are four stocks in the Diversified Entertainment space, and they are: AMC Networks Inc. (NASDAQ: AMCX), CBS Corp. (NYSE: CBS), Comcast Corp. (NASDAQ: CMCSA), and Lions Gate Entertainment Corp. (NYSE: LGF-A). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

AMC Networks

On Wednesday, shares in New York headquartered AMC Networks Inc. recorded a trading volume of 519,919 shares. The stock ended the session 0.44% lower at $51.97. The Company's shares have gained 4.53% in the last month and 1.19% over the previous three months. The stock is trading 0.96% above its 50-day moving average. Moreover, shares of AMC Networks, which owns and operates various cable television's brands delivering content to audiences, and a platform to distributors and advertisers in the US and internationally, have a Relative Strength Index (RSI) of 53.80.  

On April 05th, 2018, AMC Networks announced that it will issue a press release reporting its Q1 2018 results on May 10th, 2018, prior to the market opening. The Company will host a conference call at 8:30 a.m. ET that same day to discuss its results. The conference call will be webcast live under the "Investors" heading of the Company's website. Get the full research report on AMCX for free by clicking below at: www.wallstequities.com/registration/?symbol=AMCX

CBS Corp.

New York headquartered CBS Corp.'s stock closed the day 0.06% higher at $51.17 with a total trading volume of 1.07 million shares. The Company's shares have advanced 0.71% in the past month. The stock is trading 2.79% below its 50-day moving average. Additionally, shares of CBS, which operates as a mass media company worldwide, have an RSI of 45.40. Free research on CBS can be accessed at: www.wallstequities.com/registration/?symbol=CBS

Comcast

Shares in Philadelphia, Pennsylvania headquartered Comcast Corp. recorded a trading volume of 22.87 million shares. The stock ended yesterday's trading session flat at $33.27. The Company's shares are trading below their 50-day moving average by 8.05%. Furthermore, shares of Comcast, which operates as a media and technology company worldwide, have an RSI of 36.37.  

On April 06th, 2018, research firm Pivotal Research Group reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $52 a share to $48 a share.

On April 17th, 2018, Comcast Cable, one of the primary businesses of Comcast, announced that it is launching a new internet service that will deliver speeds up to 1 Gigabit-per-second to residential and business customers in Vermont. These speeds will be among the fastest and most widely available and will include access to the US' largest Wi-Fi network of more than 19 million hotspots. The Company plans to launch 1 Gig service to the majority of its service areas in Vermont throughout 2018. Visit WallStEquities.com now and sign up for the free research on CMCSA at: www.wallstequities.com/registration/?symbol=CMCSA

Lions Gate Entertainment

Santa Monica, California headquartered Lions Gate Entertainment Corp.'s stock finished Wednesday's session 0.86% lower at $26.45 with a total trading volume of 423,003 shares. The Company's shares have advanced 2.52% over the past year. The stock is trading below its 50-day moving average by 5.19%. Additionally, shares of Lions Gate, which engages in motion picture production and distribution, television programming and syndication, home entertainment, interactive ventures and games, and location-based entertainment in Canada, the US, and internationally, have an RSI of 47.13.  

On April 12th, 2018, Lions Gate has signed a first-look producing deal with Salma Hayek Pinault, one of the industry's premier multi-hyphenates, along with her producing partner Jose "Pepe" Tamez.  Under the agreement, Hayek Pinault and Tamez will produce feature films for the Company under Hayek Pinault's Ventanarosa Productions banner. The free technical report on LGF-A is available at: www.wallstequities.com/registration/?symbol=LGF-A

--

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

 

SOURCE Wall St. Equities


These press releases may also interest you

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:30
Blue Owl Capital Inc. ("Blue Owl") , a leading alternative asset manager, announced today the hiring of Alicia Gregory as a Managing Director based in Sydney.   Alicia brings over 25 years of investing experience with deep relationships and...

at 22:00
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...

at 21:38
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...

at 21:30
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: